Outlook Therapeutics Inc (NAS:OTLK)
$ 1.805 -0.225 (-11.08%) Market Cap: 42.70 Mil Enterprise Value: 48.72 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 34/100

Q2 2024 Outlook Therapeutics Inc Earnings Call Transcript

May 16, 2024 / 12:30PM GMT
Release Date Price: $7.33 (-1.35%)
Operator

Hello, and welcome to the Outlook Therapeutics' inaugural quarterly update conference call and webcast. (Operator Instructions)

Note that this webcast is being recorded at the company's request and a replay will be made available on the company's website following the end of the event. It is now my pleasure to turn the call over to Jenene Thomas of Investor Relations.

Jenene Thomas
Outlook Therapeutics Inc - IR Contact Officer

Thank you, Darryl. At this time, I would like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations or future projections. These are forward-looking statements and involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws and are based on Outlook Therapeutics' current expectations, and actual results could differ materially.

As a result, you should not place undue reliance on any forward-looking statements. Some of the factors that could cause actual results to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot